Literature DB >> 22191001

Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics.

Meenakshi Upreti1, Azemat Jamshidi-Parsian, Nathan A Koonce, Jessica S Webber, Sunil K Sharma, Alexzander Aa Asea, Mathew J Mader, Robert J Griffin.   

Abstract

Classic cancer research for several decades has focused on understanding the biology of tumor cells in vitro. However, extending these findings to in vivo settings has been impeded owing to limited insights on the impact of microenvironment on tumor cells. We hypothesized that tumor cell biology and treatment response would be more informative when done in the presence of stromal components, like endothelial cells, which exist in the tumor microenvironment. To that end, we have developed a system to grow three-dimensional cultures of GFP-4T1 mouse mammary tumor and 2H11 murine endothelial cells in hanging drops of medium in vitro. The presence of 2H11 endothelial cells in these three-dimensional cocultures was found to sensitize 4T1-GFP tumor cells to chemotherapy (Taxol) and, at the same time, protect cells from ionizing radiation. These spheroidal cultures can also be implanted into the dorsal skinfold window chamber of mice for fluorescence imaging of vascularization and disease progression/treatment response. We observed rapid neovascularization of the tumor-endothelial spheroids in comparison to tumor spheroids grown in nude mice. Molecular analysis revealed pronounced up-regulation of several proangiogenic factors in the tumor tissue derived from the tumor-endothelial spheroids compared with tumor-only spheroids. Furthermore, the rate of tumor growth from tumor-endothelial spheroids in mice was faster than the tumor cell-only spheroids, resulting in greater metastasis to the lung. This three-dimensional coculture model presents an improved way to investigate more pertinent aspects of the therapeutic potential for radiation and/or chemotherapy alone and in combination with antiangiogenic agents.

Entities:  

Year:  2011        PMID: 22191001      PMCID: PMC3243660          DOI: 10.1593/tlo.11187

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  50 in total

Review 1.  Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.

Authors:  Léon C L van Kempen; William P J Leenders
Journal:  Eur J Cell Biol       Date:  2005-11-11       Impact factor: 4.492

2.  Differential effects of dose rate and superfractionation on survival and cell cycle of V79 cells from spheroid and monolayer culture.

Authors:  P Fritz; K J Weber; C Frank; M Flentje
Journal:  Radiother Oncol       Date:  1996-04       Impact factor: 6.280

3.  Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells.

Authors:  Y Tang; P Borgstrom; J Maynard; J Koziol; Z Hu; A Garen; A Deisseroth
Journal:  Cancer Gene Ther       Date:  2007-01-19       Impact factor: 5.987

4.  Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy.

Authors:  R J Griffin; B W Williams; J C Bischof; M Olin; G L Johnson; B W Lee
Journal:  Technol Cancer Res Treat       Date:  2007-12

5.  Engineering tumors with 3D scaffolds.

Authors:  Claudia Fischbach; Ruth Chen; Takuya Matsumoto; Tobias Schmelzle; Joan S Brugge; Peter J Polverini; David J Mooney
Journal:  Nat Methods       Date:  2007-09-02       Impact factor: 28.547

6.  Endothelial cell migration and vascular endothelial growth factor expression are the result of loss of breast tissue polarity.

Authors:  Amy Chen; Ileana Cuevas; Paraic A Kenny; Hiroshi Miyake; Kimberley Mace; Cyrus Ghajar; Aaron Boudreau; Mina J Bissell; Mina Bissell; Nancy Boudreau
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

7.  A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer.

Authors:  Martin Trepel; Charlotte A Stoneham; Hariklia Eleftherohorinou; Nicholas D Mazarakis; Renata Pasqualini; Wadih Arap; Amin Hajitou
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

8.  Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.

Authors:  Martin Buess; Michal Rajski; Brigitte M L Vogel-Durrer; Richard Herrmann; Christoph Rochlitz
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

9.  Murine endothelial cell lines as models of tumor endothelial cells.

Authors:  Jennifer Walter-Yohrling; Sharon Morgenbesser; Cecile Rouleau; Rebecca Bagley; Michelle Callahan; William Weber; Beverly A Teicher
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

10.  (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.

Authors:  Ting Luo; Jiao Wang; Yancun Yin; Hui Hua; Jing Jing; Xiangming Sun; Minjing Li; You Zhang; Yangfu Jiang
Journal:  Breast Cancer Res       Date:  2010-01-15       Impact factor: 6.466

View more
  46 in total

Review 1.  Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.

Authors:  Samuel S Linton; Samantha G Sherwood; Kelly C Drews; Mark Kester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-07-07

2.  A three-dimensional in vitro model of tumor cell intravasation.

Authors:  Seema M Ehsan; Katrina M Welch-Reardon; Marian L Waterman; Christopher C W Hughes; Steven C George
Journal:  Integr Biol (Camb)       Date:  2014-06       Impact factor: 2.192

3.  3D spheroids' sensitivity to electric field pulses depends on their size.

Authors:  Laure Gibot; Marie-Pierre Rols
Journal:  J Membr Biol       Date:  2013-03-22       Impact factor: 1.843

4.  Tumor microenvironment and nanotherapeutics.

Authors:  Meenakshi Upreti; Amar Jyoti; Pallavi Sethi
Journal:  Transl Cancer Res       Date:  2013-08-01       Impact factor: 1.241

Review 5.  Molecular analysis of circulating tumour cells-biology and biomarkers.

Authors:  Matthew G Krebs; Robert L Metcalf; Louise Carter; Ged Brady; Fiona H Blackhall; Caroline Dive
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

6.  Mammary Organoids and 3D Cell Cultures: Old Dogs with New Tricks.

Authors:  Jakub Sumbal; Zuzana Budkova; Gunnhildur Ásta Traustadóttir; Zuzana Koledova
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-11-18       Impact factor: 2.673

7.  Three-Dimensional Printed Stamps for the Fabrication of Patterned Microwells and High-Throughput Production of Homogeneous Cell Spheroids.

Authors:  Tomas Gonzalez-Fernandez; Alejandro J Tenorio; J Kent Leach
Journal:  3D Print Addit Manuf       Date:  2020-06-05       Impact factor: 5.449

Review 8.  The role of photodynamic therapy in overcoming cancer drug resistance.

Authors:  Bryan Q Spring; Imran Rizvi; Nan Xu; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2015-04-09       Impact factor: 3.982

9.  Real-time monitoring of circulating tumor cell (CTC) release after nanodrug or tumor radiotherapy using in vivo flow cytometry.

Authors:  Nathan A Koonce; Mazen A Juratli; Chengzhong Cai; Mustafa Sarimollaoglu; Yulian A Menyaev; Judith Dent; Charles M Quick; Ruud P M Dings; Dmitry Nedosekin; Vladimir Zharov; Robert J Griffin
Journal:  Biochem Biophys Res Commun       Date:  2017-08-16       Impact factor: 3.575

10.  Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Authors:  Meenakshi Upreti; Azemat Jamshidi-Parsian; Scott Apana; Marc Berridge; Daniel A Fologea; Nathan A Koonce; Ralph L Henry; Robert J Griffin
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.